Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

By now you’ve probably heard that eating too much red and processed meat is bad for you. Not only is it associated with increased rates of coronary heart disease, stroke, and type 2 diabetes, but there is also convincing evidence that red and processed meat can cause cancer.

The cancer agency of the World Health Organisation (WHO) classifies the consumption of red meat, which includes beef, lamb, and pork, as carcinogenic – or having the potential to cause cancer if eaten in processed form. This includes hot dogs (frankfurters), ham, sausages, corned beef, and beef jerky – as well as canned meat and meat-based preparations and sauces.

Read the full article on The Conversation website, written by Marco Springmann, Senior Researcher in the Nuffield Department of Population Health. You can also read more on the University of Oxford website.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

 

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.